Skip to main content
SpringerLink
Log in

miR-126 inhibits cell proliferation and induces cell apoptosis of hepatocellular carcinoma cells partially by targeting Sox2

  • Research Article
  • Published:
Human Cell Aims and scope Submit manuscript

Abstract

Hepatocellular carcinoma (HCC) is the fifth most common malignancy and the third leading cause of cancer-related death globally. MicroRNAs (miRNAs) represent a new cohort of gene regulators. Currently, a large number of miRNAs have been reported to be associated with the initiation and maintenance of HCC. Through evaluating the relative concentrations of HCC-associated circulating miRNAs, underexpression of miR-126 has been identified in the blood of HCC patients. However, the exact function of miR-126 on HCC cellular biology progression and relative mechanisms were unclear. In this paper, we explored the function of miR-126 on HCC cells through exogenously transfecting HCC cells with miR-126 mimic. Restored miR-126 expression inhibited cell proliferation, arrest cell cycle progression, and induced cell apoptosis of HepG2 HCC cells. Moreover, to explore the mechanism of miR-126-mediated tumor suppression, we searched the putative targets of miR-126 using prediction program. Surprisingly, we found that sex-determining region Y-box 2 (Sox2) was a putative target gene of miR-126. Further luciferase assays, mRNA and protein assays consistently validated the target role of Sox2. Through restoring the expression of Sox2 in miR-126-transfected HepG2 cells, we found that overexpression of Sox2 could partially abrogate the miR-126-mediated suppression of cell growth. Thus, our data identified miR-126 as a tumor suppressor in HCC through, at least partially by targeting Sox2. This may provide novel diagnostic and therapeutic options for human HCC in future.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Worns MA, Galle PR. Future perspectives in hepatocellular carcinoma. Dig Liver Dis. 2010;42(Suppl 3):S302–9. doi:10.1016/s1590-8658(10)60521-x.

    Article  PubMed  Google Scholar 

  2. Caldwell S, Park SH. The epidemiology of hepatocellular cancer: from the perspectives of public health problem to tumor biology. J Gastroenterol. 2009;44(Suppl 19):96–101. doi:10.1007/s00535-008-2258-6.

    Article  PubMed  Google Scholar 

  3. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116(2):281–97.

    Article  CAS  PubMed  Google Scholar 

  4. Chen K, Rajewsky N. The evolution of gene regulation by transcription factors and microRNAs. Nat Rev Genet. 2007;8(2):93–103. doi:10.1038/nrg1990.

    Article  CAS  PubMed  Google Scholar 

  5. Kong YW, Ferland-McCollough D, Jackson TJ, Bushell M. microRNAs in cancer management. Lancet Oncol. 2012;13(6):e249–58. doi:10.1016/s1470-2045(12)70073-6.

    Article  CAS  PubMed  Google Scholar 

  6. Koberle V, Kronenberger B, Pleli T, Trojan J, Imelmann E, Peveling-Oberhag J, et al. Serum microRNA-1 and microRNA-122 are prognostic markers in patients with hepatocellular carcinoma. Eur J Cancer (Oxford, England: 1990). 2013. doi:10.1016/j.ejca.2013.06.002.

  7. Zhang QH, Sun HM, Zheng RZ, Li YC, Zhang Q, Cheng P, et al. Meta-analysis of microRNA-183 family expression in human cancer studies comparing cancer tissues with noncancerous tissues. Gene. 2013;527(1):26–32. doi:10.1016/j.gene.2013.06.006.

    Article  CAS  PubMed  Google Scholar 

  8. Saito Y, Hibino S, Saito H. Alterations of epigenetics and microRNA in hepatocellular carcinoma. Hepatol Res. 2013;. doi:10.1111/hepr.12147.

    Google Scholar 

  9. Nikolic I, Plate KH, Schmidt MH. EGFL7 meets miRNA-126: an angiogenesis alliance. J Angiogenesis Res. 2010;2(1):9. doi:10.1186/2040-2384-2-9.

    Article  Google Scholar 

  10. Harris TA, Yamakuchi M, Ferlito M, Mendell JT, Lowenstein CJ. MicroRNA-126 regulates endothelial expression of vascular cell adhesion molecule 1. Proc Natl Acad Sci USA. 2008;105(5):1516–21. doi:10.1073/pnas.0707493105.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  11. Liu B, Peng XC, Zheng XL, Wang J, Qin YW. MiR-126 restoration down-regulate VEGF and inhibit the growth of lung cancer cell lines in vitro and in vivo. Lung Cancer (Amsterdam, Netherlands). 2009;66(2):169–75. doi:10.1016/j.lungcan.2009.01.010.

    Article  Google Scholar 

  12. Wong QW, Lung RW, Law PT, Lai PB, Chan KY, To KF, et al. MicroRNA-223 is commonly repressed in hepatocellular carcinoma and potentiates expression of Stathmin1. Gastroenterology. 2008;135(1):257–69. doi:10.1053/j.gastro.2008.04.003.

    Article  CAS  PubMed  Google Scholar 

  13. Otsubo T, Akiyama Y, Hashimoto Y, Shimada S, Goto K, Yuasa Y. MicroRNA-126 inhibits SOX2 expression and contributes to gastric carcinogenesis. PLoS One. 2011;6(1):e16617. doi:10.1371/journal.pone.0016617.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  14. Leonardo TR, Schultheisz HL, Loring JF, Laurent LC. The functions of microRNAs in pluripotency and reprogramming. Nat Cell Biol. 2012;14(11):1114–21. doi:10.1038/ncb2613.

    Article  CAS  PubMed  Google Scholar 

  15. Yang T, Zheng ZM, Li XN, Li ZF, Wang Y, Geng YF, et al. MiR-223 modulates multidrug resistance via downregulation of ABCB1 in hepatocellular carcinoma cells. Exp Biol Med (Maywood, NJ). 2013. doi:10.1177/1535370213497321.

  16. Lim L, Balakrishnan A, Huskey N, Jones KD, Jodari M, Ng R, et al. MiR-494 within an oncogenic MicroRNA megacluster regulates G1/S transition in liver tumorigenesis through suppression of MCC. Hepatology (Baltimore, MD). 2013. doi:10.1002/hep.26662.

  17. Wang PY, Sun YX, Zhang S, Pang M, Zhang HH, Gao SY, et al. Let-7c inhibits A549 cell proliferation through oncogenic TRIB2 related factors. FEBS Lett. 2013;587(16):2675–81. doi:10.1016/j.febslet.2013.07.004.

    Article  CAS  PubMed  Google Scholar 

  18. Kogure T, Kondo Y, Kakazu E, Ninomiya M, Kimura O, Shimosegawa T. Involvement of miRNA-29a in epigenetic regulation of transforming growth factor-beta-induced epithelial–mesenchymal transition in hepatocellular carcinoma. Hepatol Res. 2013;. doi:10.1111/hepr.12188.

    Google Scholar 

  19. de Giorgio A, Castellano L, Krell J, Stebbing J. Crosstalk-induced loss of miR-126 promotes angiogenesis. Oncogene. 2013;. doi:10.1038/onc.2013.317.

    PubMed  Google Scholar 

  20. Yin X, Li YW, Jin JJ, Zhou Y, Ren ZG, Qiu SJ, et al. The clinical and prognostic implications of pluripotent stem cell gene expression in hepatocellular carcinoma. Oncol Lett. 2013;5(4):1155–62. doi:10.3892/ol.2013.1151.

    PubMed Central  CAS  PubMed  Google Scholar 

  21. Huang P, Qiu J, Li B, Hong J, Lu C, Wang L, et al. Role of Sox2 and Oct4 in predicting survival of hepatocellular carcinoma patients after hepatectomy. Clin Biochem. 2011;44(8–9):582–9. doi:10.1016/j.clinbiochem.2011.02.012.

    Article  CAS  PubMed  Google Scholar 

  22. Yuan H, Corbi N, Basilico C, Dailey L. Developmental-specific activity of the FGF-4 enhancer requires the synergistic action of Sox2 and Oct-3. Genes Dev. 1995;9(21):2635–45.

    Article  CAS  PubMed  Google Scholar 

  23. Bylund M, Andersson E, Novitch BG, Muhr J. Vertebrate neurogenesis is counteracted by So1–3 activity. Nat Neurosci. 2003;6(11):1162–8. doi:10.1038/nn1131.

    Article  CAS  PubMed  Google Scholar 

  24. Wegner M. From head to toes: the multiple facets of Sox proteins. Nucleic Acids Res. 1999;27(6):1409–20.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  25. Hussenet T, Dali S, Exinger J, Monga B, Jost B, Dembele D, et al. SOX2 is an oncogene activated by recurrent 3q26.3 amplifications in human lung squamous cell carcinomas. PLoS One. 2010;5(1):e8960. doi:10.1371/journal.pone.0008960.

    Article  PubMed Central  PubMed  Google Scholar 

  26. Saigusa S, Tanaka K, Toiyama Y, Yokoe T, Okugawa Y, Ioue Y, et al. Correlation of CD133, OCT4, and SOX2 in rectal cancer and their association with distant recurrence after chemoradiotherapy. Ann Surg Oncol. 2009;16(12):3488–98. doi:10.1245/s10434-009-0617-z.

    Article  PubMed  Google Scholar 

  27. Jia X, Li X, Xu Y, Zhang S, Mou W, Liu Y, et al. SOX2 promotes tumorigenesis and increases the anti-apoptotic property of human prostate cancer cell. J Mol Cell Biol. 2011;3(4):230–8. doi:10.1093/jmcb/mjr002.

    Article  CAS  PubMed  Google Scholar 

  28. Sun C, Sun L, Li Y, Kang X, Zhang S, Liu Y. Sox2 expression predicts poor survival of hepatocellular carcinoma patients and it promotes liver cancer cell invasion by activating Slug. Med Oncol (Northwood, London, England). 2013;30(2):503. doi:10.1007/s12032-013-0503-1.

    Article  Google Scholar 

  29. Lin F, Lin P, Zhao D, Chen Y, Xiao L, Qin W, et al. Sox2 targets cyclinE, p27 and survivin to regulate androgen-independent human prostate cancer cell proliferation and apoptosis. Cell Prolif. 2012;45(3):207–16. doi:10.1111/j.1365-2184.2012.00812.x.

    Article  CAS  PubMed  Google Scholar 

  30. Li N, Li X, Huang S, Shen S, Wang X. [miR-126 inhibits colon cancer proliferation and invasion through targeting IRS1, SLC7A5 and TOM1 gene]. Zhong nan da xue xue bao Yi xue ban = J Cent South Univ Med Sci. 2013;38(8):809–17. doi:10.3969/j.issn.1672-7347.08.009.

    CAS  Google Scholar 

Download references

Acknowledgments

This work was supported by national natural science foundation of China (No. 81101693).

Conflict of interest

None declared.

Author information

Authors and Affiliations

  1. Department of Radiation Oncology, The Third Affiliated Hospital of Kunming Medical University, Kunming, 650118, Yunnan, People’s Republic of China

    Chunfang Zhao, Ya Li, Ming Zhang, Yi Yang & Li Chang

  2. Department of Radiation Oncology, The Tumor Hospital of Yunnan Province, No. 519 of Kunzhou Road, Kunming, 650118, Yunnan, People’s Republic of China

    Chunfang Zhao, Ya Li, Ming Zhang, Yi Yang & Li Chang

Authors
  1. Chunfang Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ya Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ming Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yi Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Li Chang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Li Chang.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhao, C., Li, Y., Zhang, M. et al. miR-126 inhibits cell proliferation and induces cell apoptosis of hepatocellular carcinoma cells partially by targeting Sox2 . Human Cell 28, 91–99 (2015). https://doi.org/10.1007/s13577-014-0105-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13577-014-0105-z

Keywords

Search

Navigation